Why Fish Oil Fails: A Comprehensive 21st Century Lipids-Based Physiologic Analysis (Many of these points I make in my lecture, From Oil to Nuts: The Essential Facts on Fats. I dont see why the same conclusion would not apply to concentrated algae sources of EPA/DHA also) The medical community suffered three significant fish oil failures/setbacks in 2013. Claims that fish oils EPA/DHA would stop the progression of heart disease were crushed when The Risk and Prevention Study Collaborative Group (Italy) released a conclusive negative finding regarding fish oil for those patients with high risk factors but no previous myocardial infarction. Fish oil failed in all measures of CVD prevention—both primary and secondary. Another major 2013 setback occurred when fish oils DHA was shown to significantly increase prostate cancer in men, in particular, high-grade prostate cancer, in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) analysis by Brasky et al. Another monumental failure occurred in 2013 whereby fish oils EPA/DHA failed to improve macular degeneration. In 2010, fish oils EPA/DHA failed to help Alzheimers victims, even those with low DHA levels. These are by no means isolated failures. The promise of fish oil and its so-called active ingredients EPA / DHA fails time and time again in clinical trials. This lipids-based physiologic review will explain precisely why there should have never been expectation for success. This review will focus on underpublicized lipid science with a focus on physiology 25. Conclusion Marine/fish oil, in the supraphysiologic, prophylactic amounts often consumed, is harmful, possibly even more harmful than trans fats. If proper physiologic amounts were utilized (
Posted on: Sun, 27 Apr 2014 11:37:46 +0000
Trending Topics
Recently Viewed Topics
© 2015